Woong Ray Kim, MD | UniHealth

Offices

1 location · Mayo Clinic Arizona · 1,618 clinicians in this group

Looking this up.

Hospitals listed: Mayo Clinic Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kim’s office at (480) 301-8000 to ask if they take your plan before you enroll.

California Medical Board record

Licence C131598 · Current

Licensed to practise in California · since 2014 · expires 2028-03-31 · Seoul National University College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Mayo Clinic HospitalPhoenix, AZAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Mayo Clinic Health System, which runs 26 hospitals in 5 statesHome of Mayo Clinic Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 5 of 5 · 93% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — SSI - Colon Surgery: 1.616, Oct 2024 – Sep 2025Better than the national rate — Abdominopelvic accidental puncture or laceration rate: 0.36 (0 to 0.99) · 5,539 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 115.44 (80.81 to 150.07) · 306 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.58) · 16,145 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.486, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.56, Oct 2024 – Sep 2025

See every measure and the patient survey for Mayo Clinic Hospital

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 4 better, 7 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Mayo Clinic Hospital

SSI - Colon SurgeryInfections	1.616	Worse	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	0.36 (0 to 0.99) · 5,539 cases	Better	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	115.44 (80.81 to 150.07) · 306 cases	Better	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.21 (0 to 0.58) · 16,145 cases	Better	Jul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.486	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.56	Better	Oct 2024 – Sep 2025
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.91 (0.75 to 1.08)	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.9 · 96 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.2 · 144 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	8.3 · 271 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	7.7 · 884 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	11.2 · 1,245 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	10.9 · 274 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.3 · 5,311 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.22 (0.06 to 0.38) · 17,299 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.19 (0.04 to 0.35) · 19,712 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	4.12 (2.86 to 5.38) · 6,130 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	2.24 (1.25 to 3.22) · 3,321 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	3.17 (2.23 to 4.11) · 5,145 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	9.11 (6.21 to 12) · 3,094 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.66 (3.86 to 7.47) · 3,309 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.85 (0.68 to 3.02) · 2,189 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	6.9 · 107 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.682	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.477	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	2.73	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	13.9 · 228 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19.8 · 776 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	-3.8 · 280 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-18.9 · 1,023 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	-9 · 1,336 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.8 · 1,118 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	6.3 (4.5 to 8.8) · 469 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	9.6 (7.2 to 12.7) · 469 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	6 · 112 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	12.2 · 69 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	17.8 · 130 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	15.7 (12.7 to 19.3) · 2,211 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	1 (0.9 to 1.2) · 3,441 cases	No different	Jan 2024 – Dec 2024

What patients said (1,947 patients answered, 35% of those asked)

Sort by

Patient survey stars by topic at Mayo Clinic Hospital

Cleanliness	4
Nurse communication	5
Doctor communication	5
Communication about medicines	4
Discharge information	5
Overall hospital rating	5
Quietness	5
Recommend hospital	5

Sort by

Share of patients giving the best answer at Mayo Clinic Hospital

Room was "always" clean	80%
Nurses "always" communicated well	88%
Doctors "always" communicated well	86%
Staff "always" explained	70%
Yes, staff "did" give patients this information	93%
Yes, staff "did" give patients information about help after discharge	93%
Doctors "always" explained things so they could understand	81%
Doctors "always" listened carefully	86%
Doctors "always" treated them with courtesy and respect	92%
Patients who gave a rating of "9" or "10" (high)	91%
Staff "always" explained new medications	83%
Nurses "always" explained things so they could understand	84%
Nurses "always" listened carefully	86%
Nurses "always" treated them with courtesy and respect	93%
"Always" quiet at night	70%
"YES", patients would definitely recommend the hospital	93%
Staff "always" explained possible side effects	57%
Yes, staff "did" give patients information about possible symptoms	93%

Original Medicare doctor bills

$6,060

Medicare paid this office $6,060 for 53 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	24	$2,420	$97
Long return visit (40+ min)	14	$1,587	$113

Who their Medicare patients are

53 Original Medicare patients in 2024. Average age 71 · Women 45% · Health risk score 2.26. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.

Conditions among them: High blood pressure 62% · Diabetes 26% · Chronic kidney disease 25%.

The office billed $25,739, Medicare allowed $9,057 and paid $6,060; for 64 services of 6 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	53	64	71	2.26	$25,739	$6,060
2023	107	131	72	2.01	$65,595	$12,906
2022	194	309	71	1.73	$173,718	$33,740
2021	158	303	71	1.65	$191,079	$34,041
2020	124	205	71	2.19	$113,484	$18,583
2019	116	224	70	2.00	$81,319	$18,158
2018	95	185	71	2.14	$38,260	$14,446
2017	51	103	69	2.19	$25,869	$7,559
2016	52	91	70	1.84	$19,963	$6,294
2015	144	221	67	2.22	$63,529	$15,196
2014	61	64	65	1.71	$13,977	$4,760
2013	31	43	70	1.28	$7,449	$5,096

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	29	$3,635	$110
New patient visit (60+ min)	24	$3,349	$140
Return visit (30+ min)	30	$2,345	$73
Long return visit (40+ min)	14	$2,128	$125
Measurement of liver stiffness	11	$77	$7

2022: 6 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	75	$10,678	$112
New patient visit (60+ min)	39	$6,533	$168
Return visit (30+ min)	54	$5,120	$79
Long return visit (40+ min)	15	$4,661	$123
New patient visit (45+ min)	27	$3,181	$118
Measurement of liver stiffness	18	$164	$9

2021: 6 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	68	$11,284	$114
New patient visit (60+ min)	43	$6,776	$158
Return visit (30+ min)	55	$5,970	$84
Long return visit (40+ min)	12	$4,577	$127
New patient visit (45+ min)	21	$2,647	$126
Measurement of liver stiffness	14	$133	$9

2020: 4 services

Sort by

Original Medicare services billed in 2020

Long return visit (40+ min)	67	$8,992	$100
New patient visit (60+ min)	17	$2,564	$151
Return visit (30+ min)	30	$2,166	$64
New patient visit (45+ min)	19	$2,113	$111

2019: 6 services

Sort by

Original Medicare services billed in 2019

Long return visit (40+ min)	41	$4,989	$92
New patient visit (45+ min)	30	$3,230	$108
Long return visit (40+ min)	14	$2,982	$90
Return visit (30+ min)	31	$2,249	$62
Measurement of liver stiffness	17	$208	$12
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	14	$63	$4

2018: 6 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	36	$2,896	$69
Long return visit (40+ min)	17	$2,494	$96
New patient visit (45+ min)	21	$2,163	$103
Long return visit (40+ min)	19	$2,068	$98
Return visit (30+ min)	24	$1,907	$68
Measurement of liver stiffness	12	$116	$10

2017: 2 services

Sort by

Original Medicare services billed in 2017

Return visit (30+ min)	39	$3,839	$65
Long return visit (40+ min)	11	$2,092	$100

2016: 2 services

Sort by

Original Medicare services billed in 2016

Return visit (30+ min)	33	$3,239	$59
New patient visit (45+ min)	15	$1,730	$115

2015: 3 services

Sort by

Original Medicare services billed in 2015

Return visit (30+ min)	101	$9,068	$61
Long return visit (40+ min)	21	$1,497	$71
Return visit (30+ min)	15	$1,240	$77

2014: 1 service

Sort by

Original Medicare services billed in 2014

Return visit (30+ min)	42	$2,993	$70

Drugs they prescribed that Part D paid

$37,996

Pharmacies billed $37,996 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 144) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.

125 generic and 19 brand-name prescriptions · $37,996 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Entecavir	14	$1,972	$141
Ursodiol	14	$1,971	$141
Fludrocortisone Acetate	14	$112	$8
Prednisone	14	$33	$2
Pantoprazole	12	$28	$2

Year by year

Sort by

Part D prescribing by year

2024	144	24	0% (0)	13%	$37,996
2023	446	53	0% (0)	18%	$146,598
2022	382	65	0% (0)	21%	$147,857
2021	312	59	0% (0)	29%	$151,223
2020	319	47	0% (0)	39%	$356,294
2019	287	54	None	30%	$123,708
2018	270	53	None	None	$394,294
2017	191	28	None	29%	$301,877
2016	330	47	None	25%	$831,256
2015	441	64	None	31%	$1,770,960
2014	98	26	None	20%	$220,452
2013	117	20	None	21%	$24,558

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 14 drugs

Sort by

Part D drugs prescribed in 2023

Vemlidy	43	$61,194	$1,423
Xifaxan	11	$33,697	$3,063
Entecavir	35	$10,649	$304
Ursodiol	45	$9,664	$215
Tacrolimus	39	$3,795	$97
Spironolactone	16	$411	$26
Fludrocortisone Acetate	23	$384	$17
Carvedilol	18	$325	$18
Famotidine	22	$262	$12
Mirtazapine	11	$215	$20
Levothyroxine	18	$155	$9
Prednisone	19	$92	$5
Sulfamethoxazole-Trimethoprim	12	$69	$6
Pantoprazole	14	$37	$3

2022: 10 drugs

Sort by

Part D drugs prescribed in 2022

Vemlidy	41	$56,082	$1,368
Entecavir	65	$13,654	$210
Eliquis	11	$5,665	$515
Ursodiol	19	$5,377	$283
Tacrolimus	46	$3,979	$87
Fludrocortisone Acetate	16	$219	$14
Famotidine	17	$142	$8
Pantoprazole	14	$137	$10
Levothyroxine	12	$81	$7
Furosemide	13	$49	$4

2021: 8 drugs

Sort by

Part D drugs prescribed in 2021

Vemlidy	34	$44,364	$1,305
Xifaxan	11	$27,573	$2,507
Entecavir	40	$16,699	$417
Ursodiol	20	$5,272	$264
Tacrolimus	37	$3,163	$85
Fludrocortisone Acetate	21	$360	$17
Famotidine	11	$120	$11
Furosemide	22	$118	$5

2020: 9 drugs

Sort by

Part D drugs prescribed in 2020

Xifaxan	21	$56,223	$2,677
Vemlidy	43	$52,064	$1,211
Entecavir	44	$13,399	$305
Ursodiol	32	$6,596	$206
Tacrolimus	43	$4,075	$95
Azathioprine	11	$535	$49
Spironolactone	13	$386	$30
Pantoprazole	12	$189	$16
Furosemide	13	$157	$12

2019: 11 drugs

Sort by

Part D drugs prescribed in 2019

Vemlidy	43	$48,775	$1,134
Xifaxan	13	$30,286	$2,330
Entecavir	29	$11,723	$404
Sirolimus	11	$4,225	$384
Tenofovir Disoproxil	16	$2,942	$184
Ursodiol	17	$2,466	$145
Tacrolimus	16	$1,253	$78
Mycophenolate Mofetil	12	$818	$68
Spironolactone	28	$546	$20
Pantoprazole	15	$124	$8
Furosemide	16	$114	$7

2018: 7 drugs

Sort by

Part D drugs prescribed in 2018

Vemlidy	35	$46,928	$1,341
Entecavir	28	$21,629	$772
Tacrolimus	14	$1,695	$121
Mycophenolate Mofetil	12	$1,018	$85
Spironolactone	30	$610	$20
Pantoprazole	15	$72	$5
Furosemide	15	$33	$2

2017: 6 drugs

Sort by

Part D drugs prescribed in 2017

Vemlidy	23	$23,609	$1,026
Entecavir	24	$21,636	$901
Tacrolimus	16	$2,092	$131
Spironolactone	29	$566	$20
Pantoprazole	13	$68	$5
Furosemide	14	$67	$5

2016: 13 drugs

Sort by

Part D drugs prescribed in 2016

Harvoni	20	$634,330	$31,716
Xifaxan	19	$51,483	$2,710
Entecavir	20	$15,642	$782
Viread	12	$12,091	$1,008
Ursodiol	18	$7,811	$434
Tacrolimus	24	$2,747	$114
Ribasphere	12	$1,030	$86
Spironolactone	40	$790	$20
Alendronate	13	$167	$13
Ranitidine	17	$148	$9
Furosemide	22	$116	$5
Pantoprazole	13	$92	$7
Gabapentin	13	$29	$2

2015: 10 drugs

Sort by

Part D drugs prescribed in 2015

Harvoni	45	$1,427,525	$31,723
Xifaxan	33	$55,153	$1,671
Entecavir	22	$27,168	$1,235
Ursodiol	57	$21,577	$379
Tacrolimus	17	$2,066	$122
Ribasphere	12	$1,196	$100
Propranolol	21	$1,154	$55
Spironolactone	51	$856	$17
Azathioprine	12	$520	$43
Furosemide	36	$159	$4

2014: 1 drug

Sort by

Part D drugs prescribed in 2014

Omeprazole	14	$244	$17

2013: 2 drugs

Sort by

Part D drugs prescribed in 2013

Ursodiol	12	$1,952	$163
Spironolactone	22	$885	$40

Money from drug and device companies

$22,721 in 2025

Sort by

Industry payments by year

2025	2	6	$21,779	$22,721
2022	2	7	$17,960	$29,782
2021	1	1	$3,390	$3,390
2020	1	4	$15,575	$15,575
2019	4	48	$50,775	$66,822

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Novo Nordisk	None	$22,671	5 payments Consulting · 2025-11-04 · $983 Travel · 2025-06-24 · $435 Consulting · 2025-06-24 · $20,796 Travel · 2025-06-24 · $307 Meals · 2025-06-24 · $150
Gilead Sciences	None	$50	1 payment Meals · 2025-11-09 · $50

See all 6 published payments

Sort by

Every published payment

Gilead Sciences	Meals · 2025-11-09	None	$50
Novo Nordisk	Consulting · 2025-11-04	None	$983
Novo Nordisk	Travel · 2025-06-24	None	$435
Novo Nordisk	Consulting · 2025-06-24	None	$20,796
Novo Nordisk	Travel · 2025-06-24	None	$307
Novo Nordisk	Meals · 2025-06-24	None	$150

See earlier years (2022, 2021, 2020, 2019)

2022: $29,782

Sort by

Payments by company in 2022

Gilead Sciences	Epclusa	$29,702	6 payments Consulting · 2022-10-04 · $3,080 Consulting for Epclusa · 2022-06-25 · $1,780 Consulting · 2022-05-25 · $10,900 Travel · 2022-03-09 · $11,742 Consulting · 2022-01-11 · $510 Consulting · 2022-01-11 · $1,690
Intercept Pharmaceuticals	Ocaliva	$81	1 payment Meals for Ocaliva · 2022-06-24 · $81

2021: $3,390

Sort by

Payments by company in 2021

Gilead Sciences	None	$3,390	1 payment Consulting · 2021-11-03 · $3,390

2020: $15,575

Sort by

Payments by company in 2020

Gilead Sciences	Vemlidy	$15,575	4 payments Consulting · 2020-12-14 · $4,740 Consulting · 2020-12-08 · $1,350 Consulting for Epclusa · 2020-11-02 · $2,710 Consulting for Vemlidy · 2020-10-19 · $6,775

2019: $66,822

Sort by

Payments by company in 2019

Gilead Sciences	Vemlidy	$63,260	43 payments Consulting · 2019-12-10 · $2,500 Consulting · 2019-11-25 · $3,490 Consulting · 2019-11-19 · $1,000 Meals · 2019-11-11 · $113 Meals · 2019-11-10 · $62 Meals · 2019-11-07 · $77 Consulting · 2019-10-22 · $6,230 Consulting · 2019-10-15 · $12,480 Consulting · 2019-09-23 · $6,230 Meals · 2019-09-08 · $33 Meals · 2019-09-08 · $50 Meals · 2019-09-07 · $33 Meals · 2019-09-07 · $50 Meals · 2019-09-07 · $76 Travel · 2019-09-06 · $433 Travel · 2019-09-06 · $486 Travel · 2019-09-05 · $5,100 Travel · 2019-07-17 · $3,625 Travel · 2019-07-16 · $72 Travel · 2019-07-16 · $145 Travel · 2019-07-16 · $308 Meals · 2019-07-16 · $31 Meals · 2019-07-16 · $43 Travel · 2019-07-15 · $98 Travel · 2019-07-15 · $254 Travel · 2019-06-12 · $1,947 Meals · 2019-06-11 · $35 Meals · 2019-06-11 · $42 Travel · 2019-06-10 · $169 Travel · 2019-06-10 · $765 Meals · 2019-06-10 · $39 Consulting for Vemlidy · 2019-05-23 · $3,800 Travel for Vemlidy · 2019-05-23 · $60 Travel for Vemlidy · 2019-05-23 · $326 Meals for Vemlidy · 2019-05-23 · $4 Meals for Vemlidy · 2019-05-23 · $38 Meals for Vemlidy · 2019-05-23 · $49 Meals for Vemlidy · 2019-05-23 · $50 Consulting · 2019-05-22 · $1,430 Consulting · 2019-01-22 · $10,340 Travel · 2019-01-04 · $322 Travel · 2019-01-04 · $742 Meals · 2019-01-04 · $83
Eisai	Lenvima	$1,958	2 payments Consulting for Lenvima · 2019-02-15 · $1,875 Meals for Lenvima · 2019-01-17 · $83
Bayer HealthCare Pharmaceuticals	Stivarga	$1,525	2 payments Consulting for Stivarga · 2019-02-20 · $1,400 Meals for Stivarga · 2019-01-18 · $125
Salix Pharmaceuticals a division of Bausch Health US	Xifaxan	$79	1 payment Meals for Xifaxan · 2019-06-17 · $79

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Sort by

Research payments by company and study

Roche TCRC, Inc. · Chb Patients With Chronic Hepatitis B · 2024	Their institution	$49,518

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1114999570
Licence: AZ 70565, CA C131598, MN 37410California C131598: Current · expires 2028-03-31
Group: Mayo Clinic Arizona
Gender: Male

More record details

Sole proprietor: No
Medicaid ID: MN 171719700
Taxonomy: Federal specialty code 207RG0100X (207RG0100X)
Mailing address: 13400 E Shea Blvd, Scottsdale, AZ, 85259
NPI first listed: 2006-02-01
NPI last updated: 2024-10-20
NPI record certified: 2024-10-20

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 1804 Embarcadero Rd, Palo Alto, CA, 94303 · 300 Pasteur Dr, Stanford, CA, 94305

This office lists an electronic records connection.